Cargando…
Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial
PURPOSE: To investigate if topical chlorhexidine 0.2%, which is low cost and easy to formulate, is noninferior to topical natamycin 5% for the treatment of filamentous fungal keratitis. DESIGN: Randomized controlled, single-masked, noninferiority clinical trial. PARTICIPANTS: Adults attending a tert...
Autores principales: | Hoffman, Jeremy J., Yadav, Reena, Sanyam, Sandip D., Chaudhary, Pankaj, Roshan, Abhishek, Singh, Sanjay K., Mishra, Sailesh K., Arunga, Simon, Hu, Victor H., Macleod, David, Leck, Astrid, Burton, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037000/ https://www.ncbi.nlm.nih.gov/pubmed/34896126 http://dx.doi.org/10.1016/j.ophtha.2021.12.004 |
Ejemplares similares
-
Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial
por: Hoffman, Jeremy John, et al.
Publicado: (2020) -
Delay in accessing definitive care for patients with microbial keratitis in Nepal
por: Hoffman, Jeremy J., et al.
Publicado: (2022) -
Microbial Keratitis in Nepal: Predicting the Microbial Aetiology from Clinical Features
por: Hoffman, Jeremy J., et al.
Publicado: (2022) -
Diagnosis of Fungal Keratitis in Low-Income Countries: Evaluation of Smear Microscopy, Culture, and In Vivo Confocal Microscopy in Nepal
por: Hoffman, Jeremy J., et al.
Publicado: (2022) -
Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit
por: Nejabat, Mahmood, et al.
Publicado: (2016)